Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/1711

TDMS Study 05102-05 Pathology Tables


                              INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)
                                                       BENZETHONIUM CHLORIDE


NTP Experiment-Test: 05102-05                                                                                     Report: PEIRPT05
Study Type: CHRONIC                                                                                               Date: 05/19/95
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  121-54-0

       Lock Date:  01/24/92

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05102-05  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: CHRONIC                                       BENZETHONIUM CHLORIDE                                   Date: 05/19/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                    0MG/KG      .15MG/KG     0.5MG/KG     1.5MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially in Study                          60           60           60           60                                     
  Scheduled Sacrifice                                  9            7            9            7                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                13           11           13           13                                     
    Natural Death                                     14            9           12           16                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                24           33           26           24                                     
  Animals Examined Microscopically                    60           60           60           60                                     
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Small, Jejunum                           (1)                                                                           
   Liver                                              (60)                                   (60)                                   
   Mesentery                                          (4)                                    (4)                                    
      Fat, Liposarcoma                                 1 (25%)                                                                      
   Pancreas                                           (60)                                   (60)                                   
   Salivary Glands                                    (60)                                   (60)                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (19)                                   (21)                                   
      Adenoma                                                                                 1 (5%)                                
   Adrenal Medulla                                    (10)                                   (2)                                    
      Pheochromocytoma Benign                          3 (30%)                                                                      
      Bilateral, Pheochromocytoma Benign                                                      1 (50%)                               
   Islets, Pancreatic                                 (60)                                   (60)                                   
      Carcinoma                                                                               1 (2%)                                
   Pituitary Gland                                    (60)                                   (60)                                   
      Pars Distalis, Adenoma                          28 (47%)                               28 (47%)                               
      Pars Distalis, Adenoma, Multiple                 1 (2%)                                                                       
      Pars Distalis, Carcinoma                         2 (3%)                                 2 (3%)                                
   Thyroid Gland                                      (60)                                   (60)                                   
      Bilateral, C-Cell, Adenoma                       1 (2%)                                                                       
      C-Cell, Adenoma                                 10 (17%)                                5 (8%)                                
      C-Cell, Carcinoma                                1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                             Page   2                                                               
NTP Experiment-Test: 05102-05  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: CHRONIC                                       BENZETHONIUM CHLORIDE                                   Date: 05/19/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                    0MG/KG      .15MG/KG     0.5MG/KG     1.5MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (59)                                   (59)                                   
      Adenoma                                          4 (7%)                                 4 (7%)                                
      Carcinoma                                                                               2 (3%)                                
   Ovary                                              (60)                                   (60)                                   
   Uterus                                             (60)                                   (60)                                   
      Polyp Stromal                                    3 (5%)                                 7 (12%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (60)                                   (59)                                   
   Lymph Node                                         (5)                                    (1)                                    
   Lymph Node, Mandibular                             (7)                                    (3)                                    
      Osteosarcoma, Metastatic, Bone                                                          1 (33%)                               
   Lymph Node, Mesenteric                             (5)                                    (3)                                    
   Spleen                                             (60)                                   (60)                                   
   Thymus                                             (54)                                   (56)                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (60)                                   (60)                                   
      Adenoma                                          2 (3%)                                 2 (3%)                                
      Adenoma, Multiple                                1 (2%)                                                                       
      Carcinoma                                                                               1 (2%)                                
      Fibroadenoma                                    14 (23%)                               12 (20%)                               
      Fibroadenoma, Multiple                           3 (5%)                                 5 (8%)                                
      Fibroma                                                                                 1 (2%)                                
   Skin                                               (60)         (60)         (60)         (60)                                   
      Basosquamous Tumor Malignant                                                            1 (2%)                                
      Basosquamous Tumor Benign                        1 (2%)                                                                       
      Trichoepithelioma                                                          1 (2%)                                             
      Subcutaneous Tissue, Lipoma                      1 (2%)                                 1 (2%)                                
      Subcutaneous Tissue, Neurofibrosarcoma                                     1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                             Page   3                                                               
NTP Experiment-Test: 05102-05  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: CHRONIC                                       BENZETHONIUM CHLORIDE                                   Date: 05/19/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                    0MG/KG      .15MG/KG     0.5MG/KG     1.5MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (60)                                   (60)                                   
      Mandible, Osteosarcoma                                                                  1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)                                   (60)                                   
      Carcinoma, Metastatic, Pituitary Gland           2 (3%)                                 2 (3%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)                                   (60)                                   
      Carcinoma, Metastatic, Thyroid Gland             1 (2%)                                                                       
   Nose                                               (60)                                   (60)                                   
      Nares, Squamous Cell Papilloma                   1 (2%)                                                                       
      Vomeronasal Organ, Squamous Cell Carcinoma       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)                                   (60)                                   
   Urinary Bladder                                    (60)                                   (60)                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SYSTEMIC LESIONS                                                                                                                   
   Multiple Organs                                   *(60)        *(60)        *(60)        *(60)                                   
      Leukemia Mononuclear                            18 (30%)                               18 (30%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
     *   Number of animals with any tissue examined microscopically                                                                 
                                                             Page   4                                                               
NTP Experiment-Test: 05102-05  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: CHRONIC                                       BENZETHONIUM CHLORIDE                                   Date: 05/19/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                    0MG/KG      .15MG/KG     0.5MG/KG     1.5MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
TUMOR SUMMARY                                                                                                                       
                                                                                                                                    
   Total Animals with Primary Neoplasms (b)            46                       2          50                                       
     Total Primary Neoplasms                           96                       2          93                                       
                                                                                                                                    
   Total Animals with Benign Neoplasms                 41                       1          42                                       
     Total Benign Neoplasms                            73                       1          67                                       
                                                                                                                                    
   Total Animals with Malignant Neoplasms              23                       1          21                                       
     Total Malignant Neoplasms                         23                       1          26                                       
                                                                                                                                    
   Total Animals with Metastatic Neoplasms              3                                   3                                       
     Total Metastatic Neoplasm                          3                                   3                                       
                                                                                                                                    
   Total Animals with Malignant Neoplasms                                                                                           
   Uncertain Primary Site                                                                                                           
                                                                                                                                    
   Total Animals with Neoplasms Uncertain-                                                                                          
   Benign or Malignant                                                                                                              
     Total Uncertain Neoplasms                                                                                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Primary tumors: all tumors except metastatic tumors                                                                              
                                                             Page   5                                                               
NTP Experiment-Test: 05102-05  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: CHRONIC                                       BENZETHONIUM CHLORIDE                                   Date: 05/19/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                      0MG/KG      .15MG/KG     0.5MG/KG     1.5MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially in Study                          60           60           60           60                                     
  Scheduled Sacrifice                                  8            8            5            4                                     
  Early Deaths                                                                                                                      
    Natural Death                                     12            7           11           15                                     
    Moribund Sacrifice                                25           34           34           25                                     
    Accidently Killed                                                            1                                                  
  Survivors                                                                                                                         
    Natural Death                                                                1                                                  
    Terminal Sacrifice                                15           11            8           16                                     
  Animals Examined Microscopically                    60           60           60           60                                     
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                                                                    (1)                                    
      Adenoma                                                                                 1 (100%)                              
   Intestine Large, Cecum                             (1)                                                                           
   Intestine Small, Duodenum                                                                 (3)                                    
   Intestine Small, Jejunum                           (2)                                    (1)                                    
      Adenocarcinoma                                                                          1 (100%)                              
      Adenoma                                          1 (50%)                                                                      
   Liver                                              (60)                                   (60)                                   
      Histiocytic Sarcoma                              1 (2%)                                                                       
   Mesentery                                          (8)                                    (8)                                    
      Lipoma                                           1 (13%)                                                                      
      Fat, Histiocytic Sarcoma                         1 (13%)                                                                      
   Pancreas                                           (60)                                   (60)                                   
   Pharynx                                            (1)                                                                           
      Palate, Squamous Cell Papilloma                  1 (100%)                                                                     
   Salivary Glands                                    (60)                                   (60)                                   
      Sarcoma                                          1 (2%)                                                                       
   Stomach, Forestomach                               (10)                                   (13)                                   
      Squamous Cell Papilloma                          1 (10%)                                                                      
   Tooth                                              (2)                                                                           
      Gingiva, Squamous Cell Carcinoma                 1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (59)                                   (60)                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                             Page   6                                                               
NTP Experiment-Test: 05102-05  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: CHRONIC                                       BENZETHONIUM CHLORIDE                                   Date: 05/19/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                      0MG/KG      .15MG/KG     0.5MG/KG     1.5MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (29)                                   (24)                                   
      Adenoma                                          1 (3%)                                                                       
      Squamous Cell Carcinoma, Metastatic, Lung                                               1 (4%)                                
   Adrenal Medulla                                    (27)                                   (29)                                   
      Pheochromocytoma Malignant                                                              1 (3%)                                
      Pheochromocytoma Benign                          3 (11%)                                4 (14%)                               
      Bilateral, Pheochromocytoma Benign               2 (7%)                                 3 (10%)                               
   Islets, Pancreatic                                 (60)                                   (60)                                   
      Adenoma                                          1 (2%)                                 3 (5%)                                
   Parathyroid Gland                                  (58)                                   (58)                                   
      Adenoma                                          1 (2%)                                                                       
   Pituitary Gland                                    (60)                                   (60)                                   
      Pars Distalis, Adenoma                          34 (57%)                               25 (42%)                               
      Pars Intermedia, Adenoma                         1 (2%)                                                                       
   Thyroid Gland                                      (59)                                   (60)                                   
      C-Cell, Adenoma                                  6 (10%)                                9 (15%)                               
      C-Cell, Adenoma, Multiple                        1 (2%)                                                                       
      Follicular Cell, Adenoma                         1 (2%)                                 2 (3%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (60)                                   (60)                                   
   Preputial Gland                                    (60)                                   (60)                                   
      Adenoma                                                                                 1 (2%)                                
      Carcinoma                                        1 (2%)                                                                       
      Bilateral, Carcinoma                             1 (2%)                                                                       
   Prostate                                           (60)                                   (60)                                   
   Seminal Vesicle                                    (60)                                   (60)                                   
   Testes                                             (60)                                   (60)                                   
      Bilateral, Interstitial Cell, Adenoma           24 (40%)                               30 (50%)                               
      Interstitial Cell, Adenoma                      21 (35%)                               10 (17%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (59)                                   (60)                                   
      Femoral, Histiocytic Sarcoma                     1 (2%)                                                                       
   Lymph Node                                         (8)                                    (14)                                   
      Mediastinal, Histiocytic Sarcoma                 1 (13%)                                                                      
      Renal, Histiocytic Sarcoma                       1 (13%)                                                                      
                                                             Page   7                                                               
NTP Experiment-Test: 05102-05  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: CHRONIC                                       BENZETHONIUM CHLORIDE                                   Date: 05/19/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                      0MG/KG      .15MG/KG     0.5MG/KG     1.5MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - cont                                                                                                         
      Thoracic, Squamous Cell Carcinoma,                                                                                            
          Metastatic, Lung                                                                    1 (7%)                                
   Lymph Node, Mandibular                             (13)                                   (17)                                   
      Hemangiosarcoma                                  1 (8%)                                                                       
   Lymph Node, Mesenteric                             (9)                                    (14)                                   
   Spleen                                             (60)                                   (60)                                   
      Hemangiosarcoma                                  1 (2%)                                                                       
      Histiocytic Sarcoma                              2 (3%)                                 1 (2%)                                
   Thymus                                             (52)                                   (51)                                   
      Squamous Cell Carcinoma, Metastatic, Lung                                               1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (55)                                   (53)                                   
      Adenoma                                          1 (2%)                                                                       
      Fibroadenoma                                     1 (2%)                                 3 (6%)                                
      Fibroma                                          3 (5%)                                 1 (2%)                                
      Histiocytic Sarcoma                              1 (2%)                                                                       
   Skin                                               (60)         (60)         (60)         (60)                                   
      Basal Cell Adenoma                                                         1 (2%)                                             
      Basosquamous Tumor Benign                                                  1 (2%)                                             
      Histiocytic Sarcoma                              1 (2%)                                                                       
      Keratoacanthoma                                  1 (2%)                    3 (5%)                                             
      Squamous Cell Papilloma                          1 (2%)                                 1 (2%)                                
      Sebaceous Gland, Lip, Carcinoma                  1 (2%)                                                                       
      Subcutaneous Tissue, Fibroma                                               1 (2%)       1 (2%)                                
      Subcutaneous Tissue, Fibrosarcoma                             1 (2%)                                                          
      Subcutaneous Tissue, Fibrous Histiocytoma                     1 (2%)                                                          
      Subcutaneous Tissue, Histiocytic Sarcoma                                                1 (2%)                                
      Subcutaneous Tissue, Neurofibroma                1 (2%)                                                                       
   Skin, Site of Application-Mass                     (5)                       (3)          (4)                                    
      Keratoacanthoma                                                            1 (33%)      1 (25%)                               
      Sebaceous Gland, Carcinoma                                                 1 (33%)                                            
   Skin, Site of Application-No Mass                  (2)          (1)          (8)          (16)                                   
      Subcutaneous Tissue, Histiocytic Sarcoma         1 (50%)                                                                      
   Skin, Site of Application-Mass                     (5)                       (3)          (4)                                    
      Subcutaneous Tissue, Histiocytic Sarcoma         1 (20%)                                                                      
   Skin, Site of Application-No Mass                  (2)          (1)          (8)          (16)                                   
      Subcutaneous Tissue, Histiocytic Sarcoma                      1 (100%)                                                        
   Skin, Site of Application-Mass                     (5)                       (3)          (4)                                    
      Subcutaneous Tissue, Histiocytic Sarcoma                                   1 (33%)                                            
   Skin, Site of Application-No Mass                  (2)          (1)          (8)          (16)                                   
      Subcutaneous Tissue, Histiocytic Sarcoma                                                1 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                             Page   8                                                               
NTP Experiment-Test: 05102-05  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: CHRONIC                                       BENZETHONIUM CHLORIDE                                   Date: 05/19/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                      0MG/KG      .15MG/KG     0.5MG/KG     1.5MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (59)                                   (60)                                   
      Maxilla, Osteosarcoma                            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)                                   (60)                                   
      Astrocytoma NOS                                                                         1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (59)                                   (60)                                   
      Histiocytic Sarcoma                              1 (2%)                                                                       
      Squamous Cell Carcinoma                                                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                (3)                                                                           
      Squamous Cell Papilloma                          3 (100%)                                                                     
   Zymbal's Gland                                     (2)                                                                           
      Carcinoma                                        2 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)                                   (60)                                   
      Transitional Epithelium, Carcinoma               1 (2%)                                                                       
   Urinary Bladder                                    (60)                                   (60)                                   
      Transitional Epithelium, Papilloma                                                      1 (2%)                                
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SYSTEMIC LESIONS                                                                                                                   
   Multiple Organs                                   *(60)        *(60)        *(60)        *(60)                                   
      Histiocytic Sarcoma                              3 (5%)       1 (2%)       1 (2%)       3 (5%)                                
      Leukemia Mononuclear                            23 (38%)                               30 (50%)                               
      Mesothelioma Benign                                                                     1 (2%)                                
      Mesothelioma Malignant                           1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
     *   Number of animals with any tissue examined microscopically                                                                 
                                                             Page   9                                                               
NTP Experiment-Test: 05102-05  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: CHRONIC                                       BENZETHONIUM CHLORIDE                                   Date: 05/19/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:13:29  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                      0MG/KG      .15MG/KG     0.5MG/KG     1.5MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
TUMOR SUMMARY                                                                                                                       
                                                                                                                                    
   Total Animals with Primary Neoplasms (b)            57           3           8          57                                       
     Total Primary Neoplasms                          149           3           9         135                                       
                                                                                                                                    
   Total Animals with Benign Neoplasms                 55                       7          54                                       
     Total Benign Neoplasms                           111                       7          97                                       
                                                                                                                                    
   Total Animals with Malignant Neoplasms              30           3           2          33                                       
     Total Malignant Neoplasms                         38           3           2          37                                       
                                                                                                                                    
   Total Animals with Metastatic Neoplasms                                                  1                                       
     Total Metastatic Neoplasm                                                              3                                       
                                                                                                                                    
   Total Animals with Malignant Neoplasms                                                                                           
   Uncertain Primary Site                                                                                                           
                                                                                                                                    
   Total Animals with Neoplasms Uncertain-                                                                                          
   Benign or Malignant                                                                      1                                       
     Total Uncertain Neoplasms                                                              1                                       
                                                                                                                                    
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Primary tumors: all tumors except metastatic tumors                                                                              
                                                             Page  10                                                               
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------